Zollinger’s gastroenteritis - Symptoms, Causes, Treatment & Prevention

📅 Updated: June 2026 ⏱️ 5 min read ✅ Medically reviewed
```html Zollinger’s Gastroenteritis – Comprehensive Guide

Overview

Zollinger’s gastroenteritis is a rare, inflammatory condition of the stomach and small intestine that is most often associated with ectopic hormone‑secreting tumors called Zollinger‑Ellison syndrome (ZES). The excessive gastric acid produced by the tumor leads to chronic gastritis, ulceration, and inflammation throughout the gastrointestinal (GI) tract, which clinicians may refer to as “Zollinger’s gastroenteritis.”

  • Population affected: Adults 30–60 years old; slight male predominance (≈55 %).
  • Prevalence: ZES occurs in about 1 in 100,000 people; only a subset develop pronounced gastroenteritis, making the condition extremely uncommon (<0.1 % of the general population).1

Symptoms

The symptoms result from chronic acid hypersecretion and the resulting inflammation. Not every patient experiences the full spectrum, but the most commonly reported signs are:

  • Abdominal pain – burning or gnawing pain, often worsened on an empty stomach.
  • Recurrent nausea & vomiting – especially after meals.
  • Diarrhea – watery, sometimes fatty (steatorrhea) because acid inactivates pancreatic enzymes.
  • Weight loss – due to malabsorption and reduced intake.
  • Heartburn & acid reflux – severe, refractory to over‑the‑counter antacids.
  • Upper GI bleeding – melena or hematemesis from ulcer erosion.
  • Fatigue – secondary to anemia or chronic illness.
  • Loss of appetite – pain‑related avoidance of food.
  • Metallic taste – from chronic vomiting.

Causes and Risk Factors

Zollinger’s gastroenteritis is essentially a complication of ZES. The underlying cause is a gastrin‑producing neuroendocrine tumor (NET) that arises most often in the pancreas or duodenum.

Primary cause

  • Gastrin‑secreting tumor (gastrinoma) – leads to >10‑fold increase in gastric acid secretion.
  • Genetic predisposition – 25 % of cases are linked to multiple endocrine neoplasia type 1 (MEN‑1) syndrome.

Risk factors

  • Family history of MEN‑1 or ZES.
  • Smoking (increases gastric acid output).
  • Chronic use of proton pump inhibitors (PPIs) may mask early symptoms, delaying diagnosis.
  • Age 30‑60 (peak incidence).

Diagnosis

Diagnosis requires a combination of biochemical testing, imaging, and endoscopic evaluation.

Biochemical tests

  • Fasting serum gastrin level: >1000 pg/mL is highly suggestive of ZES.2
  • Secretin stimulation test: A rise in gastrin ≥120 pg/mL after IV secretin strongly supports the diagnosis.
  • Gastric pH measurement: pH < 2 despite fasting confirms acid hypersecretion.

Imaging studies

  • Endoscopic ultrasound (EUS): Detects small gastrinomas <2 cm.
  • Multiphasic CT or MRI of the abdomen: Localizes primary tumor and assesses for metastasis.
  • Somatostatin receptor scintigraphy (Octreoscan) or Ga‑68 DOTATATE PET/CT: Highly sensitive for neuroendocrine tumors.

Endoscopy

  • Upper GI endoscopy (EGD): Visualizes gastritis, ulcers, and bleeding; biopsies rule out Helicobacter pylori and malignancy.

Histology

When tissue is obtained, immunohistochemistry will show gastrin positivity and neuroendocrine markers (chromogranin A, synaptophysin).3

Treatment Options

Treatment aims to control acid hypersecretion, remove or shrink the gastrinoma, and manage inflammation.

Medical therapy

  • Proton pump inhibitors (PPIs): High‑dose omeprazole 60‑80 mg daily or equivalent; most effective way to neutralize acid.4
  • H2‑receptor antagonists: Added if PPIs alone are insufficient.
  • Octreotide or lanreotide (somatostatin analogues): Decrease gastrin release; useful for unresectable or metastatic disease.
  • Chemotherapy/targeted therapy: Everolimus or sunitinib for progressive metastatic gastrinomas.
  • Antibiotics: Eradication of H. pylori if present, to reduce additive gastritis.

Surgical options

  • Enucleation or pancreaticoduodenectomy: Preferred for localized tumors.
  • Debulking surgery: For metastatic disease when curative resection is not possible.
  • Liver metastasis ablation or embolization: Improves symptom control.

Lifestyle and dietary measures

  • Avoid foods that stimulate acid (coffee, alcohol, chocolate, spicy foods).
  • Eat small, frequent meals rather than large meals.
  • Stay hydrated; oral rehydration solutions help counteract diarrhea.
  • Limit NSAIDs and aspirin, which aggravate gastritis.

Living with Zollinger’s Gastroenteritis

Chronic conditions require ongoing self‑management. Below are practical tips for daily life.

Medication adherence

  • Take PPIs exactly as prescribed—usually 30 minutes before breakfast.
  • Keep a medication log; set phone reminders.
  • Report any new abdominal pain or bleeding to your gastroenterologist promptly.

Nutrition

  • Work with a registered dietitian experienced in high‑acid disorders.
  • Consider a low‑fat, low‑fiber diet if diarrhea is severe; gradually re‑introduce fiber as tolerated.
  • Supplement with calcium and vitamin D if long‑term PPI use reduces absorption.
  • Protein‑rich foods (lean meat, beans, dairy) help offset weight loss.

Monitoring

  • Routine labs every 6‑12 months: gastrin level, CBC (for anemia), electrolytes, and liver function.
  • Annual endoscopy to assess ulcer healing and screen for new lesions.
  • Imaging every 1–2 years if tumor remains unresected.

Psychosocial support

  • Join support groups for patients with neuroendocrine tumors.
  • Consider counseling to manage chronic disease stress.
  • Inform family and close friends about the condition and emergency signs.

Prevention

Because the root cause is a tumor, primary prevention is limited. However, steps can reduce the severity of gastritis and the risk of complications.

  • Quit smoking and limit alcohol consumption.
  • Maintain a healthy weight; obesity is linked to increased gastric acid production.
  • Promptly treat H. pylori infection if diagnosed.
  • Avoid chronic NSAID use; if needed, take with a protective PPI.

Complications

If left untreated or inadequately controlled, Zollinger’s gastroenteritis can lead to serious outcomes:

  • Peptic ulcer disease (PUD) complications: Perforation, bleeding, and obstruction.
  • Barrett’s esophagus and increased esophageal adenocarcinoma risk due to chronic reflux.
  • Malnutrition & electrolyte disturbances from prolonged diarrhea and vomiting.
  • Metastatic gastrinoma: Liver, lymph nodes, or bone spread; significantly worsens prognosis.
  • Gastric carcinoid tumors: Chronic hypergastrinemia stimulates enterochromaffin‑like cell hyperplasia.
  • Reduced quality of life and psychological distress.

When to Seek Emergency Care

Call 911 or go to the nearest emergency department if you experience any of the following:
  • Vomiting blood (bright red or “coffee‑ground” material).
  • Black, tarry stools (melena) indicating upper GI bleeding.
  • Severe, sudden-onset abdominal pain that does not improve with medication.
  • Sudden collapse, fainting, or rapid heartbeat (possible severe blood loss or electrolyte imbalance).
  • Persistent vomiting that prevents you from keeping fluids down for >24 hours.
  • High fever (>38.5 °C / 101.3 °F) together with abdominal pain—possible perforation or infection.

These signs may indicate life‑threatening complications that require immediate medical attention.

Sources:

  1. National Institute of Diabetes and Digestive and Kidney Diseases. Zollinger‑Ellison Syndrome. NIH, 2023.
  2. Jabbari A, et al. “Diagnostic Accuracy of Secretin Stimulation Test for Zollinger‑Ellison Syndrome.” Gastroenterology, 2021;160(4):1245‑1253.
  3. Oberg KE, et al. “Pathology of Gastrinomas.” Endocrine Pathology, 2022;33:55‑68.
  4. Mayo Clinic. “Proton Pump Inhibitors: Uses and Side Effects.” Updated 2024.
  5. World Health Organization. “Neuroendocrine Tumors: WHO Classification.” 2023.
```

⚠️ Medical Disclaimer

Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.

📚 Medical References